Howard Levy, Chief Medical Officer at CATALYST BIOSCIENCES, INC. (CBIO), sold 173 shares at $11.00 ($2K) on 2018-11-16, disclosed to the SEC on 2018-11-16.
Scheduled sale ($2k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CBIO | BUY | 2020-08-12 | $9K | — | Filing → |
| CBIO | BUY | 2020-03-17 | $10K | — | Filing → |